Seeing Is Believing
Checkmate Pharmaceuticals's activity chart (see below) currently has 7 price targets and 6 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 107.5 days.
Most recent stock forecast was given by from BTIG on 20-Apr-2022. First documented stock forecast 01-Sep-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Sep-2020
$9
4 years 5 months ago
(20-Apr-2022)
1/2 (50%)
$5.78 (179.50%)
20
Hold Since 01-Sep-2020
$7
4 years 11 months 13 days ago
(07-Oct-2021)
1/2 (50%)
$2.71 (63.17%)
195
What is CMPI (Checkmate Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on CMPI (Checkmate Pharmaceuticals)?
Which analyst has the most public recommendations on CMPI (Checkmate Pharmaceuticals)?
Which analyst is the currently most bullish on CMPI (Checkmate Pharmaceuticals)?
Which analyst is the currently most reserved on CMPI (Checkmate Pharmaceuticals)?